Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
Open Access
- 12 May 2016
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 127 (19) , 2327-2336
Abstract
Key Points: Hyperactivation of the BMP-SMAD pathway blunts EPO-mediated hepcidin inhibition. Lack of BMP-SMAD pathway inhibition by matriptase-2 abrogates the ERFE-mediated hepcidin suppression in response to EPO.Keywords
This publication has 38 references indexed in Scilit:
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceJournal of Clinical Investigation, 2013
- EPO-mediated reduction in Hamp expression in vivo corrects iron deficiency anaemia in TMPRSS6 deficiencyBritish Journal of Haematology, 2010
- Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cellsBlood, 2009
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane HemojuvelinCell Metabolism, 2008
- The Serine Protease TMPRSS6 Is Required to Sense Iron DeficiencyScience, 2008
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)Nature Genetics, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007
- Suppression of hepcidin during anemia requires erythropoietic activityBlood, 2006